Related Experiment Video
Updated: Apr 4, 2026
Author Spotlight: Enhanced Isolation of Interaction-Null Mutants in Yeast
Published on: December 29, 2023
Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses
Daiva M Mattis1, Adam S Chervin1, Diana R Ranoa2
1Department of Biochemistry, University of Illinois, Urbana, IL 61801, USA.
Abstract:
Bacterial lipopolysaccharide (LPS) activates the innate immune system by forming a complex with myeloid differentiation factor 2 (MD-2) and Toll-like receptor 4 (TLR4), which is present on antigen presenting cells. MD-2 plays an essential role in this activation of the innate immune system as a member of the ternary complex, TLR4:MD-2:LPS. With the goal of further understanding the molecular details of the interaction of MD-2 with LPS and TLR4, and possibly toward engineering dominant negative regulators of the MD-2 protein, here we subjected MD-2 to a mutational analysis using yeast display. The approach included generation of site-directed alanine mutants, and ligand-driven selections of MD-2 mutant libraries. Our findings showed that: (1) proline mutations in the F119-K132 loop that binds LPS were strongly selected for enhanced yeast surface stability, (2) there was a preference for positive-charged side chains (R/K) at residue 120 for LPS binding, and negative-charged side chains (D/E) for TLR4 binding, (3) aromatic residues were strongly preferred at F119 and F121 for LPS binding, and (4) an MD-2 mutant (T84N/D101A/S118A/S120D/K122P) exhibited increased binding to TLR4 but decreased binding to LPS. These studies revealed the impact of specific residues and regions of MD-2 on the binding of LPS and TLR4, and they provide a framework for further directed evolution of the MD-2 protein.
Insights
Myeloid differentiation factor 2 (MD-2) mutations were analyzed using yeast display to understand its interaction with bacterial lipopolysaccharide (LPS) and Toll-like receptor 4 (TLR4). Specific mutations impact LPS and TLR4 binding, offering insights for developing new immune system regulators.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Bacterial lipopolysaccharide (LPS) triggers the innate immune system via a complex with myeloid differentiation factor 2 (MD-2) and Toll-like receptor 4 (TLR4).
- MD-2 is crucial for the TLR4:MD-2:LPS complex formation and subsequent immune activation on antigen-presenting cells.
Purpose of the Study:
- To elucidate the molecular interactions between MD-2, LPS, and TLR4.
- To explore the potential for engineering dominant-negative MD-2 regulators through mutational analysis.
Main Methods:
- Site-directed alanine mutagenesis of MD-2 was performed.
- Yeast display technology was employed for library generation and screening.
- Ligand-driven selection identified MD-2 mutants with altered binding properties.
Main Results:
- Mutations in the F119-K132 loop enhanced MD-2 yeast surface stability and influenced LPS binding.
- Specific charged residues (R/K at 120) preferred LPS binding, while others (D/E) favored TLR4 binding.
- Aromatic residues at F119 and F121 were critical for LPS binding.
- A quadruple mutant (T84N/D101A/S118A/S120D/K122P) showed increased TLR4 binding and decreased LPS binding.
Conclusions:
- Specific MD-2 residues and regions significantly impact LPS and TLR4 binding affinities.
- These findings provide a foundation for the directed evolution of MD-2 for therapeutic applications.
- Understanding MD-2's binding dynamics is key to modulating innate immune responses.
More Related Videos
11:30Unravelling the Function of a Bacterial Effector from a Non-cultivable Plant Pathogen Using a Yeast Two-hybrid Screen
Published on: January 20, 2017
12:43Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016